| Literature DB >> 35546242 |
Akihisa Furuta1, Masaaki Yamagishi2, Goki Matsumura2, Takeshi Shinkawa2, Hiroshi Niinami2.
Abstract
OBJECTIVE: The objective of this study was to evaluate the long-term surgical results of transposition of the great arteries with left ventricular outflow tract obstruction.Entities:
Keywords: Double-outlet right ventricle; Left ventricular outflow tract obstruction; Transposition of the great arteries
Mesh:
Year: 2022 PMID: 35546242 PMCID: PMC9092694 DOI: 10.1186/s13019-022-01869-9
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.637
Fig. 1In the 1980s, the Senning and REV operations were introduced for the treatment of transposition of the great arteries with left ventricular outflow tract obstruction, in addition to the Rastelli and Mustard operations. the arterial switch and Nikaidoh operations were initiated in 1989 and 1990, however, the Nikaidoh procedure was abandoned in 1996 owing to the early mortality. The Senning and Mustard operations were discontinued in 1982 and 2001 owing to serious late complications. Subsequent attending surgeons opted to terminate the REV operation in 1999. The arterial and Rastelli operations had remained surgical options for this situation by 2017. REV, Réparation à l'Etage Ventriculaire
Patient characteristics
| Atrial switch | ASO | Nikaidoh | Rastelli | REV | |
|---|---|---|---|---|---|
| Male | 14 (70%) | 10 (71%) | 5 (71%) | 25/48 (52%) | 13 (54%) |
| Age (years) | 1.2 (0.8–3.9) | 0.3 (0.1–4.1) | 3.4 (2.3–3.9) | 5.3 (4.3–8.0) | 3.8 (2.3–6.2) |
| Body weight (kg) | 7.5 (5.7–12.6) | 4.3 (3.5–12.8) | 11.7 (10.3–12.3) | 16.7 (13.4–21.4) | 14.5 (10.1–16.1) |
Type of LVOT obstruction Valvular Subvalvular Valvular and subvalvular Atresia | 5 (25%) 13 (65%) 2 (10) None | 1 (8%) 9 (75%) 2 (17%) None | 5 (71%) 2 (29%) None None | 16 (33%) 3 (6%) 17 (35%) 12 (25%) | 7 (29%) 3 (13%) 11 (46%) 3 (13%) |
Type of ventricular septal defect Intact septum Infundibular Perimembranous Muscular Multi-level | 9 (50%) 1 (6%) 10 (50%) None None | 1 (8%) 6 (50%) 3 (21%) 1 (8%) 1 (8%) | None 1 (14%) 6 (86%) None None | None 4 (8%) 38 (79%) None 6 (13%) | None 6 (25%) 14 (58%) None 4 (17%) |
| Bicuspid pulmonary valve | 6 (30%) | 2 (17%) | 3 (43%) | 8 (17%) | 4 (17%) |
| Z-score of pulmonary diameter in valvular LVOTO | − 0.20 (− 0.21–0.19) | 0.73 (0.63–0.87) | − 0.64 (− 0.45–− 0.91) | − 3.84 (− 4.82–− 3.43) | − 1.99 (− 2.74–− 0.35) |
| Pulmonary/aorta ratio in valvular LVOTO | 0.83 ± 0.07 | 1.06 ± 0.05 | 0.65 ± 0.09 | 0.54 ± 0.13 | 0.71 ± 0.24 |
| Fractional shortening | 0.34 ± 0.09 | 0.38 ± 0.08 | 0.42 ± 0.04 | 0.37 ± 0.07 | 0.37 ± 0.06 |
| Pressure gradient in LVOT (mmHg) | 45 (30–56) | 40 (27–63) | 57.5 (35.8–66.5) | 65 (58–79) | 65 (47–73) |
ASO, arterial switch operation; LVOT (O), left ventricular outflow tract (obstruction); REV, Réparation à l'Etage Ventriculaire
Operative results
| Atrial switch | ASO | Nikaidoh | Rastelli | REV | |
|---|---|---|---|---|---|
LVOTO relief Valvotomy Subvalvular muscle resection Both | 4 (20%) 13 (65%) 2 (10%) | None 11 (92%) None | None None None | None 1 (2%) None | None None None |
Concomitant procedure VSD closure Mitral valve repair Tricuspid valve repair COA repair Distal pulmonary artery angioplasty | 11 (55%) 2 (10%) 1 (5%) None None | 5 (42%) 2 (17%) None 2 (17%) None | None 1 (14%) None None 2 (29%) | None 1 (2%) 2 (4%) None None | None None None None None |
| Perfusion time (min) | 138 ± 44 | 248 ± 32 | 242 ± 30 | 185 ± 46 | 176 ± 30 |
| Aortic cross-clamp time (min) | 79 ± 37 | 120 ± 34 | 125 ± 316 | 93 ± 36 | 94 ± 21 |
ASO, arterial switch operation; COA, coarctation of aorta; LVOT (O), left ventricular outflow tract (obstruction); REV, Réparation à l'Etage Ventriculaire; VSD, ventricular septal defect
The causes of death
| Atrial switch | ASO | Nikaidoh | Rastelli | REV | |
|---|---|---|---|---|---|
Early mortality Low output syndrome Bleeding | 1 (5%) None None | 1 (8%) 1 (8%) None | 2 (29%) 2 (29%) None | 4 (8%) 3 (6%) 1 (2%) | None None None |
Late mortality, n (%) Sudden/unknown death Arrhythmia Heart failure Bleeding Cerebrovascular event Infection/Sepsis | 3 (16%) 3 (16%) None None None None None | 2 (18%) None None None None 1 (9%) 1 (9%) | 2 (40%) 1 (20%) None None None None 1 (20%) | 9 (20%) 4 (9%) 1 (2%) 1 (2%) 1 (2%) 1 (2%) 1 (2%) | 4 (17%) 2 (8%) None 1 (4%) None None 1 (4%) |
ASO, arterial switch operation; REV, Réparation à l'Etage Ventriculaire
Fig. 2Kaplan–Meier survival curve. Kaplan–Meier survival curve is shown in the atrial switch operation (red), ASO (green), Nikaidoh (blue), Rastelli (orange), and REV (purple) groups. ASO, arterial switch operation; REV, Réparation à l'Etage Ventriculaire. a Survival. Survival at 20 years after definitive operation was 78.5 ± 9.6% in atrial switch operation group, 75.0 ± 12.5% in ASO group, 42.9 ± 18.7% in Nikaidoh group, 75.5 ± 6.5% (67.6 ± 7.9% at 30 years) in Rastelli group, and 76.7 ± 10.8% in REV group. b Freedom from reoperation. Freedom from reoperation at 20 years after definitive operation was 87.7 ± 8.3% (76.7 ± 12.6% at 30 years) in atrial switch operation group, 61.1 ± 15.7% in ASO group, 100% in Nikaidoh group, 32.1 ± 8.4% in Rastelli group (24.5 ± 8.4% at 30 years), and 85.2 ± 8.0% (42.6 ± 30.4% at 25 years) in REV group. c Freedom from RVOT-related reoperation. Freedom from RVOT-related reoperation at 20 years after definitive operation was 33.1 ± 8.9% in Rastelli group (28.4 ± 8.6% at 30 years), 90.2 ± 6.7% in REV group (42.6 ± 30.4% at 25 years), and 100% in the other groups. d. Freedom from LVOT-reoperation. Freedom from LVOT-related reoperation at 20 years after surgery was 76.4 ± 15.5% in ASO group, 76.6 ± 10.1% in Rastelli group (57.5 ± 13.9% at 30 years), and 100% in the other groups